KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings (GDRX) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $650000.0 as the latest value for Q3 2022.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to $650000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $650000.0 through Sep 2022, changed N/A year-over-year, with the annual reading at $244000.0 for FY2021, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability hit $650000.0 in Q3 2022 for GoodRx Holdings, up from $455000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q3 2020 to a low of $244000.0 in Q4 2021.
  • Historically, Non-Current Deferred Tax Liability has averaged $703600.0 across 3 years, with a median of $455000.0 in 2022.